- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Eris Lifesciences has allotted 9,468 new equity shares following the exercise of options under its ESOP-2021 Scheme. These shares were granted across 2022, 2023, and 2024, with issue prices ranging from Rs. 510.32 to Rs. 728.16 per share. This allotment increases the company's paid-up share capital from Rs. 13,61,97,325 to Rs. 13,62,06,793. For retail investors, this signifies the company's ongoing employee incentive program, leading to a minor increase in the total number of outstanding shares and a slight expansion of its capital base.